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ABSTRACT 
Structural and folding patterns of promoter regions (c-MYC, BCL) and telomeric 
(TTAGGG repeats) G-Quadruplexes were explored and their interactions with small molecules 
were tested. EAO-108 and MHI-21, symmetric heptamethine cyanines, were identified to exhibit 
strong interaction with the telomeric G-Quadruplex (mixed hybrid-1), while promoter region G-
Quadruplexes were discriminated against. ZK-26 binds strongly to the c-MYC derivative and it 
is capable of discriminating between (3+1) hybrid-1 and -2 telomeric G-Quadruplexes with an 
initial binding preference towards the latter. To aid future binding studies, a novel labeling 
method is also described in this work.      
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1 INTRODUCTION   
The fact that the Guanine-rich nucleic acid sequences could form stable structures with four 
strands (now known as G-Quadruplexes) was first mentioned in the work of David R. Davies and 
Gary Felsenfeld in 1968 [1,2]. However, since the ground breaking discovery in 1953, scientists 
believed that there was not much else to learn in the DNA structural field, and therefore, other 
macromolecules, like RNAs and proteins, required more attention. 
 Work in the DNA structural studies remained dormant for over two decades. In the 
1990s, the revolutionary work of Elizabeth Blackburn demonstrated elevated telomerase activity 
in cancer cells. It was then understood that the stabilization of the G-quadruplex DNA could 
impede the telomerase enzyme and potentially prevent cancer [3]. In addition, the G-Quadruplex 
forming sequences were also found in the promoter regions of many oncogenes, which could be 
silenced if the G-Quadruplexes were stabilized.  
 A rational design of small molecules, which could specifically target the G-Quadruplex 
DNA, remains an important topic of research in the biomedical field. However, currently there 
are still no clinically approved therapeutics available [4]. 
 
1.1 Structure 
A possible arrangement of a G-tetrad (quartet), four guanine bases connected by 
hydrogen bonds, was first proposed in 1962 [2]. Now termed a building block of the G-
quadruplexes, it consists of four guanine bases connected by Hoogsteen hydrogen bonds as 
shown in Figure 1.1. There are a total of eight hydrogen bonds: four N1-H hydrogens are 
hydrogen-bonded with O6 and four N2-H hydrogens are hydrogen-bonded with N7. Hydrogen 
bond acceptors are O6 and N7 and hydrogen bond donors are NH1 and C2NH. The surface area 
2 
of the G-quartet is approximately 135 Å2, which is approximately twice as large as the surface 
area of the canonical Watson-Crick base pair [4].  
  
 
Figure 1.1: Arrangement of the G-quadruplex building block.  
Representative figure was adopted from [5]. G-quartet consists of four guanine bases stabilized with eight 
hydrogen bonds. A cation is schematically shown in red in the center of the quartet. Most common cations are 
potassium and sodium.  
 
A G-quadruplex molecule consists of several tetrads stacked on top of each other and can 
arise from one (unimolecular), two (bimolecular) or four (tetramolecular) equivalent DNA 
strands. All G-quadruplex molecules are stabilized by cations. The most common cations are 
potassium and sodium. Because of its smaller radius, a sodium cation is in the plane of the 
quartet while potassium is situated in between the tetrads [4].  
Structural polymorphism and commonly used terminology of some unimolecular G-
quadruplex topologies are represented in Figure 1.2. Antiparallel G-Quadruplexes contain two 
strands pointing in one direction, while the other two strands point in the other direction. This 
kind of arrangement can be supported by differently arranged loops, which connect the strands. 
Diagonal loop connects two guanines located at the opposite corners of a tetrad. Diagonal loops 
3 
always connect two anti-parallel strands (two strands pointing in the opposite directions).  
Lateral loops connect guanines on the same side of the tetrad. Lateral loops also always connect 
two anti-parallel strands. Chain reversal (propeller or double-reversal side) loops are required to 
connect two parallel strands, hence their names. A propeller loop always connects guanines of 
different tetrads and sits in the groove of the quadruplex.  
It is important to note that the G-quadruplex-specific terminology has not been 
standardized yet. Across different research groups and time periods of the manuscripts, names of 
loops and structure configurations have often varied. For example, propeller, chain reversal and 
double-reversal side loop are among the terms used to describe a loop that connects two strands 
of the same orientation. 
Parallel G-Quadruplexes contain three propeller loops which are required to connect four 
parallel strands. Mixed or (3+1) G-Quadruplex structures have three strands pointing in one 
direction, while only one strand is antiparallel. Hybrid-1 and hybrid-2 are subtypes of the mixed 
topology. Both hybrid structures have two lateral loops that connect the antiparallel strands, 
while the two parallel strands are connected with the chain-reversal (propeller) loop.       
G-Quadruplex forming sequences can be conserved to TTAGGG repeats as in the case of 
human telomeric overhang or be extremely diverse if they are found in the promoter regions of 
oncogenes. Diverse topology is a feature characteristic of G-Quadruplexes. Especially non-
telomeric G-Quadruplexes, which have loops of different size and nucleotide composition, add to 
the conformational complexity.   
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Figure 1.2: Representative human telomeric DNA quadruplex structures and terminology. 
Loops connecting G-tetrads can adopt different configurations such as diagonal (D), lateral (L), and propeller 
(P). Figure was augmented with loop properties, modified and adapted from [6]. Specific G-Quadruplex 
topology described using loop configuration (such as 2xL, 1xP vs. 1xP, 2xL for hybrid-2 vs. hybrid-1) 
simplifies the analysis [4].   
 
 
1.1.1  PU-22 
The structure of the modified cMYC 22-mer (MYC22-G14T/G23T) (aka PU-22) was 
published in 2005 by Ambrus et al. [7]. Authors showed that the modified sequence formed a 
single very stable G-quadruplex structure in potassium solution. Two G-to-T mutations at 
positions 14 and 23 of the wild type MYC22 sequence (TGAGGGTGGGGAGGGTGGGGAA) 
were shown to restrict the modified sequence (TGAGGGTGGGTAGGGTGGGTAA) into one 
5 
parallel quadruplex conformation. The melting temperature was determined to be higher than 
85oC which suggested a structure of exceptional stability. A 2015 paper by Kim et al. suggests 
that the exceptional stability of PU-22 is primarily due to its structural features. If compared to 
the human telomeric G-Quadruplexes, modified c-MYC has a 5-10% larger distance between 
negatively charged phosphate groups, which leads to weaker charge repulsion [8].  
Figure 1.3 represents a schematic model of a parallel PU-22 G-Quadruplex. Three 
propeller loops connect three guanine tetrads formed from four parallel strands. Three of the four 
grooves are occupied by the loops. Two propeller loops consist of a single thymine (T) 
nucleotide, while the other propeller loop consists of T and A. Variable temperature NMR 
melting studies showed that the single nucleotide loops are more stable than the TA loop. Imino 
protons corresponding to the guanine bases 13 and 16 (which are connected by a T14A15 loop) 
are the first to disappear in the imino proton spectrum. In addition, 5’-TGA and 3’-TAA terminal 
caps were shown to adopt a well-defined conformation and serve as stabilizers. On the contrary, 
the wild type c-MYC sequence was shown to form a mixture of dynamic conformers, which had 
been a considerable obstacle for NMR structure work and therapeutics research earlier [7].  
            
6 
 
Figure 1.3: Schematic representation of PU-22 G-Quadruplex structure. 
Structure is adapted from [7]. G-quaruplex forming sequence is 5’-TGAGGGTGGGTAGGGTGGGTAA-3’. 
Loops that connect strands of the quadruplex are underlined. Guanine bases are shown as blue rectangles. 
Guanine at the fifth position is not involved in a tetrad formation while the rest are associated into G-Quartets 
by Hoogsteen hydrogen bonds. Adenine and thymine loop bases in 5’ (TGA) and 3’ (AAT) are shown as grey 
rectangles. Their possible stacking arrangements are represented in the figure. Propeller loop A and T bases 
are shown as green and red circles, respectively. Strand polarity is shown by arrow pointers. The only 
unoccupied groove of this structure is on the side pointing away from the viewer (G7, 8, 9 and G20, 21, 22).        
 
 
7 
1.1.2 BCL-2-MID 
The wild type sequence of the BCL2 gene promoter region consists of 39 nucleotides and 
has been shown to form a mixture of three G-quadruplexes stabilized with potassium cations. A 
BCL-2-MID sequence is a truncated and mutated 23-mer 
(GGGCGCGGGAGGAATTGGGCGGG). It was shown to form a stable single antiparallel 1xD, 
2xL three-quartet G-quadruplex in the presence of potassium cation represented in Figure 1.4. 
Compared to the wild-type sequence, this BCL-2-MID is a good molecular model for structural 
and therapeutic studies of the BCL2 oncogene [9]. A recent 2014 studies identified another 
highly GC-rich sequence also located upstream of P1 promoter region, and it was shown to be 
important in BCL2 transcription. The sequence was also shown to form an antiparallel G-
quadruplex of the 1xD, 2xL type. However, this intramolecular quadruplex consisted of four G-
quartets, which made imino proton NMR spectrum more complex [10].             
 
 
 
8 
 
Figure 1.4: Schematic structure of the G-Quadruplex structure formed by the BCL-2-MID sequence.  
Figure is adapted from Dai et al. [9]. The quadruplex forming sequence is                                                       
5’-GGGCGCGGGAGGAATTGGGCGGG-3’, where loops connecting quadruplex strands are underlined. 
Guanine bases associated into G-quartets by means of Hoogsteen hydrogen bonds are shown as blue 
rectangles. Guanine residues not involved in a tetrad formation are shown as either grey rectangle (G5) or as 
small black cubes. Adenine, thymine, and cytosine loop bases are shown as either grey rectangles or 
green/red circles. Orientation of bases represented as rectangles are accurate and demonstrates possible 
stacking arrangements if any. Strand polarity is shown by arrow pointers. The only propeller loop that 
occupies one groove of this quadruplex is shown on the side pointing towards the viewer and consists of one 
C20 nucleotide.         
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1.1.3 TEL-24 
One of the potassium stabilized human telomere repeat G-Quadruplex structures was 
stabilized by flanking caps (5’-TT and 3’-A) which were added on to a TTAGGG repeats 
(TTGGG(TTAGGG)3A). This major mixed (3+1) hybrid-1 form is 95% favored in potassium 
solution [11].  
 
Figure 1.5: Schematic representation of TEL-24 mixed (3+1) hybrid-1 form.   
Figure is adapted from [11]. The quadruplex forming sequence is                
5’-TTGGGTTAGGGTTAGGGTTAGGGA-3’, where loops connecting quadruplex strands are underlined. 
Guanine bases associated into G-quartets by means of Hoogsteen hydrogen bonds are shown as blue 
rectangles. All loops that connect guanines consist of TTA, where adenine and thymine bases are shown as 
green and red circles, respectively. Capping loop residues (3’ A24 and 5’ TT) are shown as grey rectangles. 
Strand polarity is shown by arrow pointers. The only propeller loop that occupies one groove of this structure 
is shown on the side pointing towards the viewer and consists of TTA nucleotides. 
         
 
10 
The minor form that comprises the other 5% in solution presented a significant challenge 
to characterize. Currently, equal amounts (50/50) of both TEL-24 hybrid-1 (major) and hybrid-2 
(minor) forms can be induced. However, we were not able to induce more than 50% of the minor 
hybrid-2 form. Different approaches have been developed to induce 50/50 ratio of the 
major/minor form. One of the methods is presented in the results section 3.1.4, while the other 
was published recently. A paper published by Bessi et al. in June 2015 described another 
induction procedure (KCl injection). Using the high field NMR and expensive labeling 
techniques, allowed the group to confirm the structure of the “minor” form, mixed (3+1) hybrid-
2. Kinetic and thermodynamic pathways were characterized and hypothetical structures of 
intermediates were proposed in the article [12].     
Both hybrid-1 and hybrid-2 G-Quadruplex structures feature three strands running in the 
same direction, which requires the presence of at least one propeller (chain-reversal) loop. The 
other two loops are lateral loops. Geometrically, the main difference between two hybrid 
structures is the order in which the loops follow. For TEL-24 sequence read in the 5’ to 3’ 
direction, the hybrid-1 structure has a propeller loop, which is followed by two lateral loops. To 
the contrary, the hybrid-2 structure has two lateral loops, which are followed by the propeller 
loop (Figure 1.5 and Figure 1.6).      
In addition, it is important to point out that the long telomeric TTAGGG repeats form 
tandem quadruplex repeats (bead-on-a-string model) connected by TTA loops. However, the 
precise mode of connection and interaction between individual G-quadruplexes is still unknown 
and difficult to elucidate from techniques that study individual single quadruplexes in solution or 
crystal [4,13].   
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Figure 1.6: "Minor" form of TEL-24. Mixed (3+1) hybrid-2 G-Quadruplex. 
Figure is adapted from [12]. The quadruplex forming sequence is                
5’-TTGGGTTAGGGTTAGGGTTAGGGA-3’, where loops connecting quadruplex strands are underlined. 
Guanine bases associated into G-quartets by means of Hoogsteen hydrogen bonds are shown as blue 
rectangles. All loops that connect guanines consist of TTA, where adenine and thymine bases are shown as 
green and red circles, respectively. Capping loop residues (3’ A24 and 5’ TT) are shown as grey rectangles. 
Strand polarity is shown by arrow pointers. The only propeller loop that occupies one groove of this structure 
is shown on the side pointing towards the viewer and consists of TTA.         
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1.2 Importance 
1.2.1 Telomeric Sequences 
A large body of research on telomeric G-quadruplex structures was compiled by Stephen 
Neidle [4]. Telomers are structures located at the ends of chromosomes, which consist of G-rich 
DNA sequences combined with different telomeric proteins. Human telomeric DNA is relatively 
large (3-15 kb). Two complementary strands, which consist of TTAGGG and AATCCC repeats, 
form a duplex DNA. In addition, a single-stranded overhang is located at the 3’-end of the 
chromosome. The DNA sequence in that region is capable of folding into a string of G-
quadruplexes when various telometic proteins are not associated with it.  
Cellular apoptosis process is triggered when the telomeric DNA has been significantly 
shortened after several replication cycles, because the DNA polymerase cannot efficiently 
replicate blunt ends. However, telomeric repeats can be added back onto the DNA sequence by 
enzyme telomerase, which usually is not present in human somatic cells. The presence of the 
telomerase in a cell makes it immortal, which was shown to have a significant (80-85%) 
implication in human cancers (osteosarcoma cells use Alternate Lengthening Pathway to 
maintain lengths of their telomeres). Therapeutics specifically targeting the enzyme telomerase 
have been under development for over two decades.  
1.2.2 Non-telomeric Sequences 
Sequences in the promoter region of c-myc capable of forming G-Quadruplexes were the 
first studied among the non-telomeric sequences [4]. Overexpression of c-MYC oncogene has 
been linked to a variety of human cancers. The transcription of the oncogene is primarily 
controlled by NHE III1, a nuclease hypersensitive element III1 of the c-MYC promoter, which is 
located upstream from the P1 promoter of the oncogene (Figure 1.7). The coding C-rich strands 
13 
of that element can adopt i-motif conformations, while the non-coding G-rich strand can adopt 
G-quadruplex conformations, which repress transcription of the c-MYC [7,8].  
 
 
Figure 1.7: Transcription regulation of c-MYC oncogene with G-Quadruplex formation.  
Figure is borrowed from [14]. The transcriptionally active complex of NHE III1 is shown with RNA Pol II 
representing RNA polymerase reading the genomic information. Transcriptionally silenced form is shown to 
form parallel G-Quadruplex on one-strand and i-motif on the complementary strand.    
 
Transcription of the BCL2 (B-cell CLL/lymphoma 2) gene is also down regulated by G-
quadruplex formation. The BCL2 gene produces a protein which is a part of the mitochondrial 
membrane. The protein was found to be an inhibitor of cell apoptosis and its overexpression was 
found in a variety of cancers, including B-cell and T-cell lymphomas. A GC-rich P1 promoter 
region and the region upstream of it were shown to regulate transcription of the BCL2 gene. 
[9,10,15].        
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1.3 Targeting with drugs 
The transcription of a gene can be stalled by formation of a G-quadruplex molecule. 
Therefore, stabilization of the G-quadruplex by small molecules will prevent RNA polymerase 
from transcribing the gene. Since the promoter region quadruplexes are generally not stacked on 
top of each other and are flanked with single-stranded loops (which connect them to the rest of 
the double stranded DNA), intercalation between the tetrads, groove binding, as well as top and 
bottom stacking of potential small molecules presents a plausible way to stabilize the 
quadruplexes [4].  
On the other hand, telomeric G-quadruplexes exist in tandem, so top and bottom stacking 
of small molecules may stabilize several G-quaruplexes at the same time and efficiently inhibit 
the telomerase activity. 
 
1.4 NMR  
Nuclear Magnetic Resonance (NMR) spectroscopy is one of the two methods used to 
determine bio-macromolecular structure at high resolution. Unlike X-ray crystallography, which 
needs a suitable crystal, NMR allows for the monitoring of the interconversion of multiple 
structural forms present in solution. In addition, thermodynamic and kinetic properties of the 
system can be studied by varying concentration, ion presence, temperature, and solvents [16]. 
Drug titration experiments shown in the results section were performed by tracking chemical 
shift changes of imino protons. Aromatic and sugar proton chemical shifts can supplement imino 
proton information.     
For all quadruplex structures used in this study the 1H assignments were published. Imino 
and aromatic proton spectra were always compared to the published spectra. Detection of 
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phosphodiester bonds in a DNA molecule provides crucial data for the structure of a DNA 
backbone. In general despite their obvious relevance 31P spectra of nucleic acids, in particular G-
Quadruplexes are rarely recorded. This is in part due to the availability of the required probe and 
the presumption of extensive resonance overlap. Only BCL-2-MID G-Quadruplex had a 31P 
proton-decoupled spectrum published ( 
Figure 1.8) [9].   
 
 
 
Figure 1.8: Phosphorus spectrum of BCL-2-MID phosphate backbone. 
1D proton decoupled 31P NMR spectrum was adopted from [9]. Phosphorus assignment accounts for every 
phosphodiester present in the BCL-2-MID G-Quadruplex.  
 
1.5 H+-Exchange Method  
A novel method which allows for selective silencing of AH8 and GH8 NMR signals has 
been developed in our lab and is currently under refinement. The aromatic region of the 
quadruplex DNA sequence rich in guanine repeats can be significantly simplified. Very 
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importantly, this method does not require expensive isotope labeling and can be carried out 
within a period of two weeks while only requiring regular DNA molecules as starting material.    
Guanine and to a lesser extent adenine exhibit a slow exchange of the protons attached to the 
carbon in position 8 shown in Figure 1.9. Exchange rates for these protons were measured in 
1976 by tritium incorporation [17]. The exchange mechanism of GH8 and AH8 involves 
donation of the proton to the base, which suggests that the rates of exchange can be altered with 
high pH, DNA strand concentration, and temperature [16].     
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Figure 1.9: The purine coding bases in DNA and RNA. 
Guanine (G) is 2-amino-6-keto purine and adenine (A) is 6-amino purine. G has an imino group at N1. Both 
guanine and adenine are connected at the sugar moiety at N9 in the imidazole ring. GH8 and AH8 are slowly 
exchangeable. Protons attached to a carbon in the 8th position resonate in the aromatics region of the NMR 
spectrum. Due to their abundance in the G-quadruplex molecules, silencing of their signals tremendously 
simplifies aromatic region of the NMR spectrum [16].  
2 MATERIALS AND METHODS 
This section outlines general guidelines for sample preparation and data acquisition. Any 
deviations to this procedure are described in the results section of the thesis. 
Guanine (G) 
Adenine (A) 
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2.1 DNA Samples 
The DNA nucleotides: PU-22 d[TG(AGGGTGGGT)2AA], BCL-2-MID 
d[GGGCGCGGGAGGAATTGGGCGGG], TEL-24 d[TT(GGGTTA)3GGGA], TEL-22 
d[AGGG[TTAGGG]3], and duplex control RI-10-mer d(GCGAATTCGC)2 were purchased from 
Integrated DNA Technologies (Coralville, IA, USA). The concentration was calculated using the 
absorbance at 260 nm from the manufacturer provided extinction coefficient. Stock solutions of 
the oligonucleotides were prepared in the doubly deionized water.  
Titration NMR samples of DNA were prepared in 90 % H2O/10% D2O, 10-20 mM TRIS 
(Tris(hydroxymethyl)aminomethane) or potassium phosphate buffer and 20-50 mM potassium 
chloride. DSS (4,4-dimethyl-4-silapentane-1-sulphonic acid) was added as an internal reference. 
EDTA (ethylenediaminetetraacetic acid) was added as a chelating agent for potential sample 
contamination with paramagnetic metals. Sample pH was adjusted to 6-7.  
2.2 Small Molecules 
Small molecules used in this study were synthesized by the research team of Dr. Maged 
Henary at GSU.    
2.3 NMR Experiments 
NMR experiments were performed on an Avance 600 spectrometer, equipped with a 5 
mm QXI 1H{31P, 13C, 15N} Bruker probe. Imino proton spectra (1024 scans for 100 uM DNA 
sample) were acquired at 35 oC using the 1-1 jump and return technique [18] and WATERGATE 
w5 [19] pulse sequence. Sweep width was adjusted to 24 ppm.   
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3     RESULTS AND DISCUSSION 
3.1 G-quadruplex structures used in this study 
Exchangeable imino protons are trapped in the hydrogen bonds formed between nucleic 
acid base pairs. They resonate approximately in the 16 to 11 ppm region of the 1D 1H NMR 
spectra of DNA sequences. The unique chemical shifts of imino protons make them a convenient 
monitor to probe for structural perturbations. Imino proton regions of PU-22 [7], BCL-2-
MID[15], and TEL-24 [11], quadruplex forming DNA sequences, were previously assigned and 
published by different research groups. 
The aromatics region of a 1H NMR spectrum is significantly more crowded and is not as 
readily available to monitor the structural perturbations. However, a novel proton-exchange 
method proposed in section 3.5 allows to efficiently silence GH8 and AH8 signals, which can 
tremendously simplify 1H NMR spectra, especially that of G-Quadruplex DNA.     
In addition to being the most abundant and sensitive proton (1H) nuclei to detect, 31P 
nucleus is also used to monitor the phosphate backbone of the DNA. Assignment of the 1D 
proton-decoupled 31P NMR spectrum of BCL-2-MID was also previously published by the same 
group [15].  
    
3.1.1 Imino protons 
G-quadruplex forming sequences found in the oncogene promoter regions were commercially 
synthesized and 1D 1H NMR spectra were recorded. Using previously published assignments, all 
NMR signals in the imino proton regions were correlated with their particular imino protons.   
Figure 3.1 shows imino proton spectrum of PU-22 recorded on a 600 MHz NMR 
instrument. Optimal conditions for NMR work were found by varying pH, salt, and temperature 
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conditions. This beautifully resolved spectrum of a parallel G-Quadruplex formed with the PU-
22 sequence was recorded at pH 6 and a temperature of 35 oC. The presence of a potassium 
counter ion is important for quadruplex formation, and the correct annealing procedure must be 
followed to obtain one predominant conformation (as described in sections 3.1.3).         
The middle tetrad of this G-Quadruplex consists of guanine bases with their imino 
protons (GH1) trapped in the hydrogen bonds between the two neighboring bases: G8, G21, 
G17, and G12. The 3’-end containing tetrad can be monitored with imino protons 9, 22, 18, and 
13, while 7, 20, 16, and 11 resonances correspond to the 5’-end containing tetrad.   
 
Figure 3.1: Imino proton region of PU-22 1H NMR spectrum.  
Each peak corresponds to one imino proton of the guanine base. Assignment was published in 2005 by 
Ambrus et al. [7].  
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The BCL-2-MID quadruplex forming sequence was also probed for the most suitable 
NMR conditions and spectrum shown in Figure 3.2 was recorded at 35 oC and pH 7. The same 
annealing procedure must also be used to ensure formation of the G-Quadruplex structure. Weak 
signals in the imino proton region suggest that more than one form is present in solution, but a 
major conformation corresponds to the one published previously [15]. Each major NMR signal 
was associated with a particular imino proton. The middle tetrad of the quadruplex can be 
monitored with signals labeled as 8, 2, 22, and 18. Intriguingly huge, the seven-nucleotide lateral 
loop consisting of A10, G11, G12, A13, A14, T15 and T16 connects guanines 9 and 17, which 
are part of the 5’-end containing tetrad. Dai et al. showed that A10 and T15 stack to the G-tetrad 
and a reversed Watson-Crick hydrogen bond was detected at a low temperature (TH3). G3, G7, 
G19, and G23 imino protons correspond to the 3’-end containing tetrad [9].    
 
Figure 3.2: Imino proton region of BCL-2-MID 1H NMR spectrum.  
Imino protons of guanine bases are assigned based on published data [15].   
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Among other biologically important G-quadruplex forming sequences are those found in 
human cells in the telomeric ends. A single-stranded DNA overhang consists of up to 30 
TTAGGG repeats. The TEL-22 sequence is a wild-type telomeric DNA sequence capable of 
folding into a mixture of two monomeric topologically different G-quadruplex structures under 
physiologically relevant conditions [20]. In the presence of potassium ions in solution, TEL-22 
was shown to fold into a mixture of different G-quadruplex topologies.      
 
Figure 3.3: Imino proton region of TEL-22 1H NMR spectrum.  
This spectrum was obtained after the wild-type TEL-22 sequence was annealed at 85oC and allowed to cool 
down over time. A mixture of structures is present in solution. Previous studies indicate that crowding, 
variable solvent conditions, and most importantly, loop nucleotide mutations are capable of inducing a single 
conformation over the mixture of structures [4].   
  
 
Certain modifications of the 3’- and 5’- ends of the TEL22 sequence were shown to 
stabilize one (3+1) conformation over the other [20]. For example, TEL-24 (5’-TT; 3’-A) can 
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fold into a thermodynamically stable hybrid-1 form. A specific procedure described in 13.1.4 has 
to be followed to achieve a confomationally pure sample. Spectrum of the TEL-24 sequence 
folded into a hybrid-1 form is shown in Figure 3.4.  
 
Figure 3.4: Imino proton region of TEL-24 1H NMR spectrum. 
Each peak corresponds to one imino proton of the guanine base. Assignment was previously published in 
2006 by Luu et al. [11]   
 
3.1.2 Phosphorus 
A DNA backbone can be directly monitored with 31P NMR spectroscopy. To our 
advantage, the PU-22 spectrum, which is shown in Figure 3.5, accounts for every phosphodiester 
in the molecule. Structural perturbations of the quadruplex can thus be easily monitored. In 
addition, Figure 3.6 shows a well resolved 31P NMR spectrum of TEL-24.  
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Figure 3.5: Proton-decoupled 31P spectrum of PU-22.  
 
 
 
Figure 3.6: Proton-decoupled 31P spectrum of TEL-24. 
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3.1.3 Multiple forms of PU-22 and BCL-2-MID  
To efficiently elucidate a single conformation from a mixture of partially-folded and 
folded quadruplex topologies, intricate annealing procedures are sometimes created. Procedures 
described below were successfully used for the specified sequences in this work, but they might 
not be the most efficient methods. 
A major form of both PU-22 and BCL-2-MID samples can be induced under similar 
conditions. A DNA powder, which was previously desalted with KCl, is pre-mixed with the 
buffer, solvent, EDTA and DSS, but the salt is not added. The mixture is heated to 85 oC for 
approximately 10 minutes. While the solution is still hot, the necessary amount of KCl is added. 
The sample is then allowed to cool down to a room temperature slowly over time.   
After the above procedure was applied to both PU-22 and BCL-2-MID sequences, imino 
proton spectra were recorded to confirm the presence of the intended conformation as a major 
form in solution.  
3.1.4 Multiple forms of TEL-24 
The procedure described in section 3.1.3 was developed independently, but it is similar to 
a common annealing procedure used to form major conformations of G-quadruplexes. It is also 
similar to the KCl injection method used by Irene Bessi et al. published very recently, which was 
used to study the TEL-24 conformers [12]. However, a different procedure to induce a 50/50 
ratio of hybrid-1/hybrid-2 confirmations of TEL-24 was independently developed in our lab 
(described below).  
It is important to note that unlike our pH-denaturation/renaturation method, the KCl 
injection method can be applied to a sample of TEL-24 only once. After the solution of KCl was 
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injected into the NMR tube, the sample would not be readily available for a second induction 
procedure. According to the published method, the sample will have to be desalted and purified 
overnight [12].       
A pH-denaturation/renaturation method of induction calls for about 10 minutes of 
preparation time on average. It is comparable to the 8 minutes reported as necessary to complete 
induction by the KCl injection method. 
 A sample of potassium-desalted TEL-24 sequence is mixed with the desired amount of 
KCl (20-50 mM used in this study) and is heated to 42 – 45 oC. The sample is then denatured 
with enough KOH to ensure unfolding, which is confirmed by NMR imino proton spectrum. We 
have observed that the final pH values in a range of 12-13 will suffice. It is important to note that 
this method does not degrade the DNA to an extent which will render it unusable. As long as the 
DNA is not kept at high pH long (we have not tried longer than 15 minutes), the method will 
work. Figure 3.7 illustrates an imino proton region of the NMR spectrum of the denatured TEL-
24. When pH is greater than the pKa of dissociation of the imino proton, which participates in the 
base-pairing, the base gets ionized and the hydrogen bond pattern is no longer formed. The imino 
proton of a guanine base has a pKa of 9.2 at 25oC and ionic strength of 0.1 [16]. No imino proton 
signals are observed because the guanine bases are not connected through Hoogsteen hydrogen 
bonds at that pH. However, currently, we do not know whether this unfolded state is similar to 
the hypothetical semi-unfolded intermediate states reported by Bessi et al. [12] and to what 
extent this unfolded state is topologically different from any of the known folded TEL-24 
structures.  
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Figure 3.7: Illustration of the minor form formation, disappearance of the minor form (at T=298 K)  
Reference: major form is labeled according to a previously published assignment corresponding to a 3+1 
hybrid-1 topology shown in Figure 1.5. The reference spectrum was recorded at T=298 K and pH=7. The 
denatured spectrum (recorded at T=298 K) shows no imino proton signals, because there is no “base-
pairing” present at pH=13. The renatured spectrum displays both major and minor form, concurrently, where 
the newly formed minor form is labeled with green circles (assignment of the minor hybrid-2 form was 
published very recently in [12]). The renatured spectrum was acquired at pH adjusted back to neutral and 
T=298 K.  Disappearance of the minor form can be monitored over time. After sufficient amount of time, 
only the major form remains visible.       
 
After the TEL-24 is denatured, a desired buffer is added to the solution (TRIS-HCl) and 
pH is adjusted to approximately 6-7.5. The rest of the NMR sample components are added at this 
time (EDTA, DSS, D2O/H2O). Then, the sample is transferred to a preheated (to the same 
temperature of 42-45 oC) NMR tube. The NMR measurements can then be started immediately 
after the necessary NMR parameters are adjusted. Figure 3.7 illustrates formation of a 50/50 
mixture of major/minor form in the renatured spectrum. Since the renaturation procedure 
together with the NMR set up time take about 10 mins, the time points of the experiment are 
adjusted accordingly. The first renatured spectrum is in fact recorded 10 minutes after the 
28 
induction. More spectra recorded over equal time intervals allow for convenient monitoring of 
the disappearance of the minor form and appearance of the major form.  
A conformationally pure major hybrid-1 form remains in solution after the minor hybrid-
2 form gets spontaneously converted over time (Figure 3.8). As illustrated in Figure 3.7, a 
spectrum of a pure hybrid-1 G-quadruplex is acquired after 48 hours at 298 K.    
 
Figure 3.8: Schematic representation of conversion between TEL-24 conformations. 
 
Several pitfalls need to be avoided for a successful induction. The pH-denaturation step, 
which calls for observation of lack of imino proton signals by NMR, can be skipped to save time; 
however, if the denaturation was not successful, the renatured form will not be exhibit a 50/50 
ratio and significantly less than 50% of the minor form will be present, e.g. 20/80.  In addition, if 
the sample is kept on the heating block for too long or if the temperature of the heating block is 
set higher than 45oC, a 50/50 ratio will not be formed. For example, if the temperature is set to 
50 oC during the renaturing step, a 40/60 ratio of the minor/major form is observed. In addition, 
we observed that TEL-24 refolds extremely slowly at temperatures lower than 288 K.    
Most importantly, a 50/50 ratio can be induced multiple times in the same sample, with 
only the total volume and potassium ion concentration change after each induction. 
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After the NMR sample is prepared, the NMR experiments can be recorded at different 
temperatures, which allows for kinetic measurements described in section 3.1.5. DNA samples of 
variable concentrations allowed us to show that the minor-to-major form conversion is 
independent of concentration in the range studied, which is expected for hybrid-2/hybrid-1 
mixtures (described in section 3.1.6).  
Physiologically relevant molecular crowding conditions are characterized by the 
restricted amount of solvent surrounding the macromolecule and by the excluded volume 
phenomenon. Volume occupied by one molecule becomes unavailable to another molecule. 
Steric repulsions created in a cell environment, can be mimicked with high concentration of 
either non-reactive crowding agent (e.g. PEG) or the macromolecules studied. Concentration of 
macromolecules in a cell environment is reported to be anywhere from 80 to 400 mg/mL [21]. If 
a particular macromolecular conformation does not change when the concentration of the 
macromolecule is elevated, then the current conformation could be considered physiologically 
relevant. Concentration dependence of up to 1.6 mM or approximately 10 mg/ml was tested for 
TEL-24.  Even though it is at least eight times lower than the cell environment, we can suggest 
that both forms of TEL-24 are potentially valid under physiological conditions in the cell.   
3.1.5 Temperature dependence of TEL-24  
Kinetic measurements and half-life values were determined from the temperature 
dependence experiments shown in Figure 3.9.   
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Figure 3.9: Representative NMR data of kinetic measurements at 288, 293, 298 K.  
Three data points (10 mins, 4.5 hours and 6 hours after minor form induction) are shown for processes 
monitored at 298 K (blue), 293 K (green) and 288 K (red).  
 
After the 50/50 induction, the intensities of the minor form peaks (corresponding to the 
imino protons locked in the hydrogen bonds of the hybrid-2 folded guadruplex) gradually 
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decrease, while the intensities of the imino protons corresponding to the major form (hybrid-1) 
increase over time. Intensities of individual hybrid-1 and hybrid-2 peaks were scrupulously 
measured and recorded. Intensities of all decreasing peaks were added together. Their sum was 
divided by the sum of the intensities of all increasing peaks. The natural logarithm of the ratio 
was taken and plotted against time. The equilibrium constant was obtained from the slope of the 
resulting best fit line, and the half-life in hours was calculated. The process was assumed to 
follow the first order kinetics. The time that the minor form peaks take to decrease to half of their 
initial intensity (recorded 10 minutes after induction) is the half-life value rounded to the nearest 
hour. It is reported in Table 3.1.  
Table 3.1: Temperature dependence of half-life (in hours) of the minor-major form conversion. 
 
 
 
 
Based on the observed behavior, the minor-major conversion process must have a 
significant kinetic barrier. Activation Energy (Ea), 23 kcal/mol, was obtained from the slope of 
the best fit line (ln(k) vs. 1/T). In addition, kinetic data reported by Bessi et al. suggests an 
activation barrier of 33 kcal/mol [12] (the value is not reported in the paper. It was calculated 
from the equilibrium constant k2r, which corresponds to the conversion of the hybrid-2 form into 
the unfolded intermediate reported in the paper). This difference is within the experimental error 
range.  
 
 
Temperature (K) Half-life (hour)       
288.0 34 
293.0 21 
298.0 9 
32 
3.1.6 Concentration dependence of TEL-24 
Measurements were also taken for DNA samples with variable concentration. Data is 
summarized in Table 3.2.  
Table 3.2: Concentration dependence of TEL-24 minor form half-life. 
 
Concentration (mM) 0.4 0.8 1.6 
Half-life (hours) 26 21 21 
 
 
Even though the half-life of the minor form in a 0.4 mM TEL-24 sample is slightly 
different from the 1.8 and 1.6 mM samples, we are inclined to conclude that the kinetic processes 
are independent of concentration. NMR is not a sensitive technique and resolution of the NMR 
spectrum is dependent on the concentration. At 0.4 mM total concentration of DNA, imino 
proton signals of each form were only 0.2 mM in concentration. This concentration is low 
enough to allow for discrepancies in the measurements. Notably, a common way to record a 
good NMR spectrum of a low concentration sample is to acquire more scans; however, it is not 
possible in the timed kinetic experiments.      
3.1.7 Kinetics of TEL-24 and Development of Therapeutics  
Both hybrid-1 and hybrid-2 forms of TEL-24 are regarded as potential targets for 
therapeutics development. A 50/50 mixture of two forms presents a convenient system to 
monitor selectivity of the drugs. However, if hybrid-2 imino protons are monitored, it is 
important to be aware of the rate of their conversion into the hybrid-1 form. Binding experiments 
monitored for longer than nine hours at 25 oC might render the data inconclusive. Successful 
selectivity studies are reported in section 3.4. 
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3.2 Targeting of PU-22 with cyanine dyes 
 
 
 
 
 
Figure 3-10: Cyanine drugs MH-4 (top) and MH-5 (bottom). 
Both compounds are symmetric trimethine cyanines. Both compounds have one positive charge on the 
cyanine system and most have charged alkyl amine substituents. MH-4 compound does not carry two 
large Br substituents on the six membered rings.  
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Binding of the MH-4 and MH-5 cyanine drugs to the PU-22 G-Quadruplex was 
monitored using perturbations of the imino proton signals of PU-22. As shown in Figure 3.3 and 
described in section 3.1.1, each imino proton signal corresponds to a particular tetrad. Figure 
3.11 illustrates titration data PU-22 with MH-4 (a) and MH-5 (b). The drugs were added to a 
constant amount of PU-22 at mole ratios of 0:1, 1:1, 2:1, 3:1, 4:1 and 6:1. The bottom spectrum 
shows imino protons of PU-22 with no drugs added.    
 
 
Figure 3.11: Imino proton spectra of MYC22 quadruplex titrated with the parent cyanine 26 (a) and 
the brominated analogue 31 (b). 
Ligands were added to the quadruplex at the ratio indicated on the plot. Selected imino protons of 
3’-end (9), middle (8), and 5’-end (16) tetrads are marked. 
 
 
Based on the imino proton shifts on titration, the primary binding site for compound MH-
4 is the 3ʹ-end tetrad of PU-22 (G9, G13, G18, and G22; Figure 3.12 (a)). A secondary binding 
site at the 5ʹ-end tetrad (G7, G11, G16, and G20) is evident after the 3ʹ-end approaches 
saturation. Remarkably, no precipitation was observed even at a 10-fold excess of either 
compound. With the exception of G8 imino proton, the middle tetrad is not affected by the 
binding on either terminal tetrad. However, it is noted that the shift of G8 imino proton parallels 
that of G16 imino proton which monitors binding to the 5ʹ-end tetrad. This suggests that the 
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binding to the 5ʹ-end tetrad causes the chemical shift change of G8 imino proton. A similar 
binding sequence (first 3ʹ-end and then 5ʹ-end) is also observed for compound MH-5 (Figure 
3.12 (b)). Interestingly, the presence of the bulkier bromine substituent results in a much smaller 
effect on the central tetrad, as shown for G8 imino proton. This is in marked contrast to the result 
obtained for compound MH-4 and indicates that there are differences in the binding orientation 
of MH-4 and MH-5 (on the 5ʹ-end tetrad). 
 
 
Figure 3.12: Imino proton titration curves of 3’-end tetrad (9), middle (8), and 5’-end (16) tetrad for 
the parent cyanine 26 (a) and the brominated analogue 31 (b). 
The primary binding site for 26 the 3’-end tetrad; a secondary binding site is at the 5’-end tetrad is evident 
after the 3’-end approaches saturation. 
 
 
The above data was published as a part of the 2013 paper [22]. Detailed NMR studies of 
the proposed groove binding mode of MH-5 with other quadruplexes are currently under 
investigation.  
 
3.3 Discrimination between Different G-Quadruplexes 
Similar to the MH-4 and MH-5 drug pair, EAO-108 and MHI-21 are only different by 
two chlorine residues attached to the six-membered rings of EAO-108 (Figure 3.13). Contrary to 
the large bromine groups present in the MH-5 molecule, chlorine residues are considerably 
smaller in size.   
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3.3.1 EAO-108 and MHI-21 
 
 
Figure 3.13: Drugs EAO-108 (top) and MHI-21 (bottom). 
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Both compounds are symmetric heptamethine cyanines. Both molecules exhibit a conjugated double bond 
character. Each compound has three positive charges. Two charges are located on the alkyl chain moieties, 
while the third positive charge is delocalized.   
 
Three dimensional representations of EAO-108 and MHI-21 are illustrated in Figure 3.14 
and Figure 3.15. The models were built in UCSF Chimera software package [23]. Both 
molecules in Figure 3.13 are represented as if they were flipped by a 90o angle towards the 
viewer. The central chlorine groups are pointing towards the observer. The conjugated ring 
system makes both molecules flat. A slight concave-up curvature, clearly observed in the space-
filling models, is of notice. Chlorine groups, although not very big, make the in-plane size of the 
EAO-108 slightly larger.    
 
 
 
 
 
Figure 3.14: Space-filling model of EAO-108.  
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Figure 3.15: Space-filling model of MHI-21. 
 
A complete set of data was acquired by titrating each drug individually with TEL-24, PU-
22, and BCL-2-MID quadruplexes.  
 
3.3.1.1 Titration with TEL-24 
Figure 3.16 illustrates the difference in the interaction of EAO-108 and MHI-21 with the 
hybrid-1 of TEL-24. Surprisingly, EAO-108 readily interacts with the bottom face (3, 21, 17, and 
9) of the quadruplex. To the contrary, the MHI-21 does not bind well at 1:1 mole ratio. The only 
imino proton signal that appears to be affected the greatest is G17, while G3 and G22 are 
moderately affected. Figure 3.17 illustrates additional titration experiment that was performed to 
confirm behavior of G17 and G4 of the TEL-24 titrated with MHI-21. At 288 K, peaks are not 
overlapped and the identity of each peak can be traced. At 1:0.5 mole ratio, the intensity of G17 
is significantly smaller than that of G4.   
When the drug is present in excess, at the 1:3 mole ratio, the mode of binding (bottom) 
does not change significantly. To the contrary, the MHI-21 does not bind well at 1:1 mole ratio, 
while more interaction with the bottom tetrad is observed at 1:3 ratio (Figure 3.18).    
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The color-coded models suggest that the drugs interact with the bottom tetrad and 
possibly with the groove of the quadruplex. Notably, that groove is the most flexible because 
loops neither occupy the groove (propeller), nor constrain it (lateral). However, the exact mode 
of interaction remains unclear. 
 
Figure 3.16: TEL‐24 quadruplex titration with EAO‐108 (left), and MHI‐21 (right).  
NMR imino proton spectra (T=298 K) of the TEL-24 quadruplex are shown on the top of the figure. EAO-
108 and MHI-21 drugs were added to a constant amount of TEL-24 indicated in terms of their mole ratios. 
The DNA is mostly present as a hybrid-1 form in solution.  Ligands were added to the quadruplex at the ratio 
indicated on the plot, where 1:0 ratio corresponds to the imino proton spectrum of TEL‐24 with no ligand 
added. Schematic structures of TEL‐24 are color coded according to the tetrad guanine imino protons affected 
in the titrations. Red residues are strongly affected, yellow are somewhat affected, and green are not affected.  
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Figure 3.17: TEL-24 quadruplex titration with MHI-21 at T=288 K.  
At T=288 K imino proton signals for G17 and G4 exhibit minimal overlap at 1:0. Titration to 1:0.5 mole 
ratio clearly shows that G17 chemical shift disappears, while the G4 imino proton signal remains.   
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Figure 3.18: TEL-24 titrated with excess EAO-108 (top) and MHI-21 (bottom). 
TEL-24 signals are broad when drugs are present in excess, which makes the analysis of the binding 
mechanism less precise. In general, both drugs preferentially interact with the bottom tetrad of the quadruplex.  
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3.3.1.2 Titration with PU-22 and BCL-2-MID 
 
Figure 3.19: PU-22 titrated with EAO-108 and MHI-21.  
PU-22 weakly interacts with both drugs. Both molecules mostly target the bottom tetrad of PU-22 (7, 11, 16, 
20).  
 
Non-telomeric G-Quadruplexes were also probed for interaction with the drugs. Titration 
of PU-22 shown in Figure 3.19 suggests weak interaction with the bottom tetrad of the parallel 
PU-22 G-quadruplex.  
 
Figure 3.20: Titration of BCL-2-MID Quadruplex with EAO-108 and MHI-21. 
MHI-21 exhibits some interaction with 9, 1 and 17, which belong to the bottom tetrad of the quadruplex. At 
1:3 ratio signal becomes unreadable due to possible precipitation. Interaction of BCL-2-MID with EAO-108 
makes all imino proton signals broader.      
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BCL-2-MID, an antiparallel 1xD, 2xL G-Quadruplex, is similar to TEL-24 in the strand 
polarity and loop arrangement. However, BCL-2-MID interacts with the EAO-108 compound 
differently (Figure 3.20).  
These preliminary studies suggest that the EAO-108 is capable of a well-localized 
binding to a telomeric TEL-24 hybrid-1 G-Quadruplex, while discriminating against non-
telomeric G-quadruplexes such as PU-22 and BCL-2-MID.  
The ability of a small molecule to discriminate between different types of G-
Quadruplexes can have a tremendous effect for potential G-Quadruplex therapeutics. For 
example, Dhamodharan et al. recently found that bisbenzimidazole carboxamide can 
discriminate c-myc-related G-Quadruplex from other telomeric G-Quadruplexes, including the 
parallel telomeric G-Quadruplex [24]. Although the parallel telomeric G-Quadruplex is thought 
to be irrelevant under physiological conditions, the discriminating ability of that small molecule 
is stunning.  
Similarly, the properties of the EAO-108 should also be closely followed. Exact binding 
modes and grounds for selectivity towards the telomeric G-Quadruplex should be explored. 
Currently, Mass Spectrometry and Surface Plasmon Resonance experiments are underway to 
confirm and augment these preliminary NMR results.             
As described in sections 3.1.3 and 3.1.4, an established annealing procedure has to be 
followed to achieve a conformationally pure sample of a G-Quadruplex. One of the pitfalls of 
these binding experiments is a possible incorrect folding of the G-Quadruplexes. For example, 
the DNA samples prepared for Mass Spectroscopy experiments have to be checked by NMR to 
ensure correct folding. In addition, the solubility of the drug in water and its stability in solution 
are crucial factors to consider when interactions with DNA are assessed. Because the DNA 
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imino protons are monitored in the NMR titration experiments, degradation of the small 
molecules can remain unnoticed and inevitably rendering the binding data invalid.   
For example, Figure 3.21 depicts an NMR spectrum of EAO-108 molecules immediately 
after it was dissolved in 100% D2O. The spectrum is pure, and all protons can be accounted for. 
However, if the solution is kept for 13 days at room temperature, it degrades by almost 50%, 
which is demonstrated in Figure 3.22.
 
Figure 3.21: Spectrum of EAO-108 immediately after powder was dissolved in 100% D2O. 
No degradation is visible and all proton signals are accounted for. 
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Figure 3.22: Degradation of EAO-108 monitored over two week period.  
The bottom spectrum was taken immediately after the drug was dissolved in D2O and the top spectrum was 
taken thirteen days later. Solution was consistently kept at room temperature. At day thirteen, at least 50% of 
the drug had degraded.  
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3.4 Targeting Different Forms of a G-Quadruplex 
This section presents two compounds (ZK-26 and A-150) which were found to be 
selective towards the minor hybrid-2 form of hybrid-1/hybrid-2 TEL-24 mixture. Their 
interaction with PU-22 is also discussed.  
3.4.1 ZK-26 
 
 
Figure 3.23: ZK-26 ontains sulfur in the five-membered rings.  
The solubility in water is very poor, soluble in 100% DMSO.  
ZK-26 has a very poor solubility in water, so the binding studies were performed using 
the 100% DMSO solution of ZK-26. Since the presence of DMSO in the DNA sample may alter 
the structure of DNA, the total amount of DMSO added to the sample (not more than 10% by 
volume) was carefully monitored. Using a separate sample of DNA, we established that the 
imino protons were not affected by the presence of 10% DMSO (the data is not shown here). 
This proves that the presence of DMSO does not alter the DNA structure. 
Similar to the easily degradable EAO-108 (section 3.3.1), ZK-26 also degrades in 
solution. In addition, the very poor solubility of the drug required us to confirm the concentration 
of the ZK-26 in solution. NMR spectrum of ZK-26 was acquired, and the method of internal 
standard was used to confirm the actual concentration of the drug in solution (described in 
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Appendix A). Mole ratios in the binding studies were refined according to the actual 
concentration ZK-26.   
3.4.1.1 Titration of ZK-26 with PU-22 
 
Figure 3.24: Titration of ZK-26 with PU-22. 
The bottom spectrum illustrates the imino protons of the parallel form of PU-22. Peaks are labeled according 
to the assignment in Figure 3.1. Peaks belonging to the same tetrad are colored the same (Figure 1.3).  
 
 
Surprisingly, a very strong binding is observed. Two sets of peaks are clearly visible at 
1:1 mole ratio. Unlike the previous titration data (Figure 3.11, chemical shift changes; and Figure 
3.16, decrease in intensities of some peaks), ZK-26-PU-22 complex stays bound long enough for 
NMR to detect two DNA species. The imino protons of the unbound PU-22 G-quadruplex have 
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the same chemical shifts as in the 0:1 spectrum. The second set of peaks, however, corresponds 
to the imino proton signals of PU-22 bound with ZK-26. Since the chemical environment of the 
imino protons is altered by the presence of the ZK-26 molecule, their chemical shift is different.      
Docking studies are underway to gain additional insight in the actual mode of binding. 
The preliminary assessment of 1:1 spectrum suggests that the ZK-26 might be binding in the 
groove of PU-22 G-Quadruplex. Three grooves of the parallel PU-22 are occupied with the 
propeller loops. Only one groove is unoccupied and it measures 10.3 Å in size.   
 
Figure 3.25: Size of the PU-22 unoccupied groove.  
Some bases are labeled (DG2 – guanine base in position 2, DT16 – thymine base in position 16).  
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3.4.1.2 Titration of ZK-26 with TEL-24 
 
 
Figure 3.26: Titration of ZK-26 with TEL-24. 
         ZK-26 preferentially binds to the minor form of TEL-24 labeled with m1—9. Correct assignment of the hybrid-
2 TEL-24 form is now available from [12]. Changes in the chemical shift of the minor form peaks are tracked 
with green circles. Major form of TEL-24 is labeled in black and blue guides are shown as a vertical 
reference.   
 
ZK-26 exhibits preferential binding with the hybrid-2 form of TEL-24. The titration was 
performed within 6 hours after the induction of the major/minor form of TEL-24. The last 
spectrum was acquired 22 hours after the induction.  
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3.4.2 Modified-ZK-26 
 
Figure 3.27: Modified ZK-26 (ZK-306). 
An alkyl chain moiety was added to a molecule of ZK-26 in order to increase its water solubility. However, 
only slightly enhanced water solubility was observed. Binding studies were performed using a DMSO 
solution of the modified-ZK-26. 
 
Even though the alkyl modification slightly improved water solubility, the complex 
aggregates at a 3:1 mole ratio. The binding of the modified-ZK-26 with the PU-22 is still strong, 
which is evident from the two sets of peaks at 1:1.    
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3.4.2.1 Titration of Modified-ZK-26 with PU-22 
 
Figure 3.28: Titration of PU-22 with Modified-ZK-26. 
 
Although the NMR spectrum quality is poor, the result is intriguing. Technically, 
aggregation of the quadruplexes might also support inhibition of the telomerase and may be a 
mechanism of the successful therapeutics agent.  
3.4.2.2 Titration of Modified-ZK-26 with TEL-24 
Modified-ZK-26 also binds to the minor, hybrid-2, form of the TEL-24. The major form 
is clearly left intact.   
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Figure 3.29: Titration of TEL-24 with Modified-ZK-26. 
Minor form of TEL-24 was induced according to the standard method. Major form is not affected by the 
binding, while hybrid-2 form labeled with m1-9 in green is affected. However, already at 0.5:1 ration the 
complex aggregates and starts to precipitate out of solution.  
 
The binding abilities of the modified-ZK-26 are similar to that of the ZK-26. Alkyl 
moiety of the modified-ZK-26 increased aggregation rates of the DNA-drug complexes. 
Although not suitable for the NMR structure work, the binding mode might present useful 
possibilities for therapeutics development.  
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3.4.3 A-150  
 
Figure 3.30: Structure of A-150 drug. 
Two bulky bromine groups are attached to the six-membered rings. 
 
A-150 is very well-soluble in water. The drug weakly interacts with the TEL-24 50/50 
mixture. A-150 preferentially interacts with the hybrid-2 until 1.5:1 ratio is reached.    
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3.4.3.1 A-150 Titration with TEL-24  
 
Figure 3.31: Titration of A-150 with TEL-24.  
Both hybrid-1 and hybrid-2 forms of TEL-24 interact with the drug. Hybrid-2 imino proton signals, which are 
affected the most, are labeled with green squares.  
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3.4.3.2 A-150 Titration with PU-22  
 
Figure 3.32: Titration of A-150 drug with PU-22 quadruplex. 
Most likely the binding occurs on the top and bottom tetrad. At 8:1 ratio, the complex precipitates out of the 
solution. 
 
 
The drug stacks to the top and the bottom tetrad of the PU-22 G-quadruplex. The 
complex precipitates at 8:1 mole ratio. Chemical shifts of 16 and 22 imino protons drastically 
change at 3:1 ratio. Titration has to be repeated with smaller increments to understand specific 
modes of interaction.  
A-150 also interacts with BCL-2-MID, but the complex precipitates at 2:1 mole ratio.  
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3.4.3.3 A-150 Titration with BCL-2-MID  
 
 
Figure 3.33: Titration of A-150 with BCL-2-MID. 
At 2:1 ratio, the complex begins to precipitate.  
 
 
 
In addition to a well-resolved imino proton spectrum of the PU-22 G-Quadruplex, its 
phosphorus spectrum can be used to monitor binding. Because the spectrum accounts for every 
phosphodiester in the molecule, it can be particularly useful to detect loop and groove 
interactions. Figure 3.34 displays two phosphorus spectra of PU-22. The bottom spectrum is of 
the PU-22 phosphate backbone. The top spectrum corresponds to the phosphate backbone of the 
PU-22 parallel G-quadruplex bound with the A-150 at 1:1 mole equivalents.  Remarkably, all 
phosphate shifts can be monitored and the 1:1 spectrum is also very well-resolved.    
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Figure 3.34: 31P spectrum of PU-22 titrated with A-150 (1:1 mole ratio). 
The top spectrum corresponds to PU-22 interacting with A-150.  
 
In addition to the imino proton and the phosphate spectrum of the G-quadruplex, 
aromatics and sugar region of the proton spectrum contain important information about the 
structural perturbations and binding interactions. To simplify aromatics region of the proton 
spectrum, a novel proton-exchange method was developed in our laboratory and is currently 
under refinement.  
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3.5 Novel Proton Exchange Method 
Guanine and adenine protons located in the eighth position (AH8 and GH8 are color 
coded in Figure 1.9) resonate in the 7-8 ppm region of the NMR proton spectrum. In addition to 
AH8 and GH8 protons, AH2, C and T H6 are also found in that region. Similarity in the 
chemical shifts of these protons leads to significant signal overlap. Since the structural research 
depends on the differentiation of the observed peaks, expensive isotope labeling is used. 
However, it is a costly and demanding process, which may be prohibitive for screening.  
A new procedure was designed to provide an alternative simple and cost-effective 
method described in section 3.5.1. It was used to exchange AH8 and GH8 with deuterium, which 
can simplify the base region of the DNA NMR spectrum. It is especially important for G-
Quadruplex DNA reach in guanine residues. Their spectra can be considerably simplified, which 
allows for a more accurate examination of grooves, loops, and the flanking sequences.   
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3.5.1 Schematic representation of the method 
 
Figure 3.35: Schematic representation of the novel proton exchange method. 
Spectra shown are based on the preliminary results obtained from a PU-22 proton-exchanged sample.  
 
 
The DNA sample is prepared in a solution of only TRIS-HCl buffer and water. The 
reference spectrum is then recorded to observe the lack of organized structure. The solvent is 
then exchanged with D2O and pH* is raised to approximately 9.5. It is important to note that the 
pH is raised using the TRIS-base in D2O. A commonly used KOH and NaOH bases should be 
avoided, because introduction of potassium and sodium cations might trigger and stabilize the G-
Quadruplex folding. The sample is then kept at an elevated temperature (65-55 oC) to speed up 
the exchange. Extent and completion of exchange can be monitored over time. A fully 
exchanged sample is then desalted with the desired cation and pH is adjusted back to 7. Non-
destructiveness of the method can be easily proved by recording an imino proton spectrum in 
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water or observing phosphodiester backbone. A selectively labeled DNA sample can then be 
used for structural and binding studies.  
3.5.2 H+ exchange of Dickerson decamer 
A Dickerson decamer, a B-DNA self-complimentary 10-mer sequence, 
d(GCGAATTCGC)2, was used as a positive control. Imino and base regions of the proton NMR 
spectrum of this well-studied 10-mer DNA were previously assigned and are shown in the 
bottom spectrum in Figure 3.36 [25]. The DNA sample AH8 and GH8 protons were selectively 
labeled with deuterium, which is evident from the top spectrum in the figure.  
 
Figure 3.36: Proton exchange of the Dickerson-Decamer DNA.  
The bottom spectrum shows a spectrum of the control 10-mer with the protons labeled according to the 
assignment published by [25]. The top spectrum is of a proton-exchange 10-mer sample, where AH8 and 
GH8 signals are significantly reduced.   
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Preliminary results were also obtained for PU-22 G-Quadruplex. Figure 3.37 compares a 
base region of the proton spectrum of control PU-22 to that of the labeled sample. When all GH8 
and AH8 signals are silenced, only AH2 and TH6 proton resonances are left. Structural 
perturbations of the loops and grooves (rich in A and T residues) can then be readily monitored. 
Currently, we are in the process of labeling other G-Quadruplex DNA samples.   
3.5.3 H+ exchange of PU-22 
 
Figure 3.37: Preliminary studies on the PU-22 G-Quadruplex labeling. 
Bottom spectrum is of the aromatic region of PU-22 folded into the parallel G-Quadruplex ([7]). Guanine H8 
are labeled in blue, adenine H8 and H2 are labeled in red, and thymine H6 are labeled in green. Top spectrum 
is the same PU-22 folded (we proved that showing the imino protons of the exchange sample briefly put in 
water) G-Quadruplex. Only remaining peaks are labeled (red: AH2 and green: TH6). 
 
4 CONCLUSIONS 
G-Quadruplex DNA is implicated in a variety of cancers and significant insights into the 
structure and function of G-Quadruplexes have been made over the years. Even though 
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development of therapeutics which could specifically target G-Quadruplexes is underway, 
no clinically approved drugs are available to date. In this work, differences in structural and 
folding patterns of representative G-Quadruplexes were studied, and new methods were 
developed to make research on G-Quadruplexes less complex and affordable. A library of 
potential drug candidates was screened. We have identified small molecules that have the 
ability to discriminate between topologies and sequences of the G-Quadruplex DNA, were 
identified and tested. Even though the preliminary results were very promising, more 
research is needed to understand the underlying mechanisms of interaction. For example, 
binding sites can be localized more precisely with NOE contacts to specific G-Quadruplex 
residues. Also, chemical shift perturbations of GH8 and H1’ protons can be monitored. 
Because those protons point into the grooves of the G-Quadruplexes, they serve as a 
convenient reporter for groove interactions. In addition, a novel labeling procedure 
developed here will also facilitate structural and drug interaction studies due to significantly 
minimized NMR shift overlaps. Although GH8 and AH8 signals will be silenced in this 
method, loop TH6 resonances can be conveniently utilized instead. Binding sites could also 
be further studied with 19F NMR. Labeled nucleotides can be synthesized in the lab at a 
lowered cost. Thymidine residues present in abundance in the G-Quadruplex loops can be 
substituted with 19F labeled deoxy-uridine. Substitution of thymine present in the capping 
loops will allow for monitoring of the stacking interactions, while labeled core loops will 
monitor the loop binding.   In addition, more studies are necessary to assess the biological 
efficacy and the mechanism of action of these drug candidates in a cell environment.  
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APPENDICES  
Appendix A (Concentration Determination of Drugs ZK-26) 
  
1. Prepare stock solution of a drug in the desired solvent, high concentration are preferred; 
2. Record approximate concentration of the drug in the stock solution; 
3. Using standard solution of DSS (known concentration) and assuming approximate 
concentration of the drug from step 2 prepare NMR sample in D2O.   
4. Record NMR spectrum using zgpr pulse sequence; 
5. Identify DSS peaks; identify major peak around 0 ppm and set it to 0.0 ppm. This is the 
reference peak. Also identify minor DSS peaks: triplet at 3.1 ppm, pentet at 1.9 ppm, 
triplet at 0.8 ppm. Intensities of each of the minor peak should be 22% of the intensity of 
the reference peak.  
6. Integrate reference peak and set integral value to 1 for a multiplicity of 9H. Integrate two 
minor DSS peaks and compare to the theoretical 0.22 value for 2H. Continue if 
consistent. 
7. Identify three peaks belonging to the drug. Identify the number of protons each peak is 
resonating from. Integrate each peak separately. 
8. Set the integral of the reference DSS peak to 9, (reference DSS peak is coming from 9 
magnetically identical protons). 
9. Calculate concentration of the drug in the NMR sample and the concentration of the stock 
solution of the drug (assuming no pipetting error was made). 
10. Example data and calculations are shown in the figures below. 
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Appendix B (Other G-Quadruplex drugs) 
Appendix B.1 (E-46) 
 
Figure 1: E-46 Cyanine Drug. 
There are no bulky substituents on the six-membered rings. The linker consists of single bonds and it is 
flexible. 
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4.1.1.1 E-46 Titration with PU-22 
 
Figure 2: Titration of E-46 with PU-22.  
Even at 16:1 ratio, the complex has not yet precipitated out of the solution. Binding occurs on the top and on 
the bottom tetrad. 
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Appendix B.2 (T-5) 
 
Figure 3 T-5 Cyanine Drug. 
There are no bulky substituents on the six-membered rings. The linker consists of double bonds and it is not 
flexible. 
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4.1.1.2 T-5 Titration with PU-22 
 
Figure 4: Titration of T-5 with PU-22.  
Even at 16:1 ratio, the complex has not yet precipitated out of the solution. Binding occurs on the top and on 
the bottom tetrad. 
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4.1.2 EAO-75, 88 
 
Figure 5: Compounds EAO-75 and EAO-88. 
The difference between the two small molecules is in the presence of a longer alkyl chain on the three ring 
system of EAO-88. Bromine anions (two per molecule) act as counter ions to neutralize any existing positive 
charges (two per molecule).   
 
 
4.1.2.1 Titration with PU-22 
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4.1.2.2 Titration with TEL-24 
 
Figure 6: TEL‐24 quadruplex titration with EAO‐75 (left) and EAO‐88 (right) followed with the imino 
proton spectra of TEL‐24.  
Ligands were added to the quadruplex at the ratio indicated on the plot, where 1:0 ratio corresponds to the 
imino proton spectrum of TEL‐24 with no ligand added. Schematic structures of TEL‐24 are color coded 
according to the imino protons affected in the titrations. Red residues are strongly affected, yellow are 
somewhat affected, and green are not affected. 
 
 
 
 
 
 
 
 
